Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$47.2M
-31.9% from 2023
Prescriptions
3.3M
$14.45 per claim
Patients
853K
208,853 prescribers
Total spending, 2024
$47.2M
$55.35 per patient
Medicare prescription drug plans paid $47.2M for Glipizide Er in 2024, for 3,266,284 prescriptions and refills to 852,852 patients (down 31.9% from 2023). The average cost per claim was $14.45.
California had the highest Medicare cost for Glipizide Er in 2024: $4.3M for 242,814 claims, followed by New York ($3.2M).
Juan D Palacios Merchan, endocrinology in Edinburg, TX, had the highest Medicare cost for Glipizide Er in 2024: 1,024 claims costing $20K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Juan D Palacios Merchan Edinburg, TX | Endocrinology | 1,024 | 306 | $20K |
| Carlos M Martinez Rivera Mayaguez, PR | Endocrinology | 1,124 | 256 | $19K |
| Edna G Melendez Reyes |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 201,658 | 3,036,203 | 787,118 | $60.3M |
| 2023 | 205,446 | 3,105,016 | 814,969 | $69.3M |
| 2024 | 208,853 | 3,266,284 | 852,852 | $47.2M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 747 |
| 142 |
| $17K |
| Stephanie Curry Johnston, RI | Internal Medicine | 634 | 151 | $15K |
| Mirna Maldonado Vega Manati, PR | Endocrinology | 332 | 88 | $15K |
| Chee-Yeung Chan Mount Kisco, NY | Endocrinology | 600 | 163 | $14K |
| Maritza Melendez Nieves Fajardo, PR | Internal Medicine | 222 | 73 | $14K |
| Neil D Kobrosky Gloucester, MA | Endocrinology | 616 | 170 | $14K |
| Daniela M Dicenso Miami, FL | Internal Medicine | 1,710 | 470 | $14K |
| Michael Correa New York, NY | Internal Medicine | 672 | 187 | $14K |
| Joshua M Tate Huntsville, AL | Endocrinology | 447 | 145 | $13K |
| Milciades Mercedes Maldonado Guaynabo, PR | Internal Medicine | 367 | 111 | $13K |
| Bin Wang Flushing, NY | Internal Medicine | 1,096 | 151 | $11K |
| Kelvin Gonzalez Soto Moca, PR | General Practice | 457 | 147 | $11K |
| Gopi K Maharaja Davenport, FL | Internal Medicine | 500 | 161 | $11K |
| Catherine K Nang Vallejo, CA | Pharmacist | 298 | 104 | $11K |
| Carlos M Acevedo Rego Guayama, PR | General Practice | 223 | 67 | $10K |
| Bao Q Nguyen Stockton, CA | Family Practice | 524 | 103 | $10K |
| Nixzaliz Rodriguez Rivera Ponce, PR | Endocrinology | 807 | 131 | $10K |
| Carlos A Pla Fernandez Tampa, FL | Endocrinology | 453 | 111 | $10K |
| Minping Liu Boston, MA | Internal Medicine | 324 | 93 | $10K |
| David R Questell Alvarado Santa Isabel, PR | Internal Medicine | 286 | 78 | $9,745 |
| Nahrain H Alzubaidi Falls Church, VA | Endocrinology | 422 | 124 | $9,693 |
| Ziad G Farah Harwich, MA | Endocrinology | 407 | 138 | $9,622 |
| Swarna Kamble Sugar Land, TX | Endocrinology | 429 | 134 | $9,442 |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Rising Pharm | 1,585,263 | $22.5M |
| Aurobindo Pharm AUROPHARMA.NS | 1,233,718 | $18.0M |
| Northstar Rx Ll | 299,963 | $4.5M |
| Actavis/Teva TEVA | 148,264 | $2.3M |
| Zydus Pharmaceu ZYDUSLIFE.NS | 120 | $1,801 |
| AHP | 68 | $698 |